Treace Medical Concepts (TMCI) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $0.62.
- Treace Medical Concepts' Debt to Equity rose 2225.63% to $0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.62, marking a year-over-year increase of 2225.63%. This contributed to the annual value of $0.47 for FY2024, which is 2287.27% up from last year.
- Latest data reveals that Treace Medical Concepts reported Debt to Equity of $0.62 as of Q3 2025, which was up 2225.63% from $0.56 recorded in Q2 2025.
- Over the past 5 years, Treace Medical Concepts' Debt to Equity peaked at $0.87 during Q4 2022, and registered a low of -$42.74 during Q1 2021.
- In the last 5 years, Treace Medical Concepts' Debt to Equity had a median value of $0.42 in 2024 and averaged -$1.79.
- Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 9920.96% in 2021, then soared by 18102.52% in 2022.
- Quarter analysis of 5 years shows Treace Medical Concepts' Debt to Equity stood at $0.32 in 2021, then skyrocketed by 176.01% to $0.87 in 2022, then tumbled by 55.87% to $0.38 in 2023, then rose by 22.87% to $0.47 in 2024, then soared by 31.38% to $0.62 in 2025.
- Its last three reported values are $0.62 in Q3 2025, $0.56 for Q2 2025, and $0.51 during Q1 2025.